Literature DB >> 30760864

Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.

Richard J Karpowicz1, John Q Trojanowski1, Virginia M-Y Lee2.   

Abstract

Cell-to-cell transmission of proteopathic alpha-synuclein (α-syn) seeds is increasingly thought to underlie the progression of neurodegenerative diseases including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and related synucleinopathies. As such, it is important to understand the chemical and biological relationships between cells and pathological aggregates of α-syn. This brief review updates our understanding of the templated spread of α-syn pathology in neurodegenerative disease from the perspective of proteopathic α-syn seeds, including how these seeds are processed by cells as well as their effects on cellular function. Recent advances in understanding the conformations of α-syn seeds are highlighted, and the possible structural basis for the observed heterogeneity of synucleinopathies is discussed. Finally, we propose the possibility that some known risk factors for synucleinopathies may in fact potentiate the cell-to-cell transmission of α-syn pathology via imbalances in interrelated cell biological processes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30760864      PMCID: PMC6609465          DOI: 10.1038/s41374-019-0195-z

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  99 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.

Authors:  Shi Zhang; Erez Eitan; Tsung-Yu Wu; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2017-09-22       Impact factor: 4.673

4.  Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.

Authors:  Jia-Yi Li; Elisabet Englund; Håkan Widner; Stig Rehncrona; Anders Björklund; Olle Lindvall; Patrik Brundin
Journal:  Mov Disord       Date:  2010-06-15       Impact factor: 10.338

5.  Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.

Authors:  Wami Marui; Eizo Iseki; Toshiki Nakai; Satoshi Miura; Masanori Kato; Kenji Uéda; Kenji Kosaka
Journal:  J Neurol Sci       Date:  2002-03-30       Impact factor: 3.181

6.  Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.

Authors:  Eric C Freundt; Nate Maynard; Eileen K Clancy; Shyamali Roy; Luc Bousset; Yannick Sourigues; Markus Covert; Ronald Melki; Karla Kirkegaard; Michel Brahic
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.

Authors:  Diego Grassi; Shannon Howard; Minghai Zhou; Natalia Diaz-Perez; Nicolai T Urban; Debbie Guerrero-Given; Naomi Kamasawa; Laura A Volpicelli-Daley; Philip LoGrasso; Corinne Ida Lasmézas
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-27       Impact factor: 11.205

8.  Direct Observation of α-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells.

Authors:  Mihaela M Apetri; Rolf Harkes; Vinod Subramaniam; Gerard W Canters; Thomas Schmidt; Thijs J Aartsma
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

9.  Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis.

Authors:  David Freeman; Rudy Cedillos; Samantha Choyke; Zana Lukic; Kathleen McGuire; Shauna Marvin; Andrew M Burrage; Stacey Sudholt; Ajay Rana; Christopher O'Connor; Christopher M Wiethoff; Edward M Campbell
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  Membrane binding, internalization, and sorting of alpha-synuclein in the cell.

Authors:  Caterina Masaracchia; Marilena Hnida; Ellen Gerhardt; Tomás Lopes da Fonseca; Anna Villar-Pique; Tiago Branco; Markus A Stahlberg; Camin Dean; Claudio O Fernández; Ira Milosevic; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2018-08-14       Impact factor: 7.801

View more
  33 in total

Review 1.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

2.  A myosin-7B-dependent endocytosis pathway mediates cellular entry of α-synuclein fibrils and polycation-bearing cargos.

Authors:  Qi Zhang; Yue Xu; Juhyung Lee; Michal Jarnik; Xufeng Wu; Juan S Bonifacino; Jingshi Shen; Yihong Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

3.  Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.

Authors:  Zachary A Sorrentino; Yuxing Xia; Kimberly-Marie Gorion; Ethan Hass; Benoit I Giasson
Journal:  FEBS Lett       Date:  2020-01-24       Impact factor: 4.124

Review 4.  Synucleinopathies.

Authors:  Elizabeth A Coon; Wolfgang Singer
Journal:  Continuum (Minneap Minn)       Date:  2020-02

Review 5.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

6.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.

Authors:  Sangjune Kim; Seung-Hwan Kwon; Tae-In Kam; Nikhil Panicker; Senthilkumar S Karuppagounder; Saebom Lee; Jun Hee Lee; Wonjoong Richard Kim; Minjee Kook; Catherine A Foss; Chentian Shen; Hojae Lee; Subhash Kulkarni; Pankaj J Pasricha; Gabsang Lee; Martin G Pomper; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  Neuron       Date:  2019-06-26       Impact factor: 17.173

Review 7.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

8.  Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.

Authors:  Rita Marreiros; Andreas Müller-Schiffmann; Svenja V Trossbach; Ingrid Prikulis; Sebastian Hänsch; Stefanie Weidtkamp-Peters; Ana Raquel Moreira; Shriya Sahu; Irina Soloviev; Suganya Selvarajah; Vishwanath R Lingappa; Carsten Korth
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

9.  Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.

Authors:  Susy Prieto Huarcaya; Alice Drobny; André R A Marques; Alessandro Di Spiezio; Jan Philipp Dobert; Denise Balta; Christian Werner; Tania Rizo; Lisa Gallwitz; Simon Bub; Iva Stojkovska; Nandkishore R Belur; Jens Fogh; Joseph R Mazzulli; Wei Xiang; Amitkumar Fulzele; Mario Dejung; Markus Sauer; Beate Winner; Stefan Rose-John; Philipp Arnold; Paul Saftig; Friederike Zunke
Journal:  Autophagy       Date:  2022-04-28       Impact factor: 13.391

10.  Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.

Authors:  Zachary A Sorrentino; Ethan Hass; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.